Trial
NCT02641392
A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Celgene
Collaborators
—
Condition
Crohn's Disease
Intervention
GED-0301
Why stopped
Study terminated by Sponsor following a recommendation from external DMC based on lack of emerging benefit; there were no new emergent safety findings
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-29